Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Wound debridement is the process of removing dead tissue from wounds. Biological debridement, enzymatic debridement, autolytic debridement, and mechanical debridement are some of the types of wound debridement. Hydrotherapy, wet-to-dry dressing, and monofilament debridement pads are the types of mechanical debridement.
Wound debridement products are used in the treatment and management of chronic ulcers, surgical wounds, traumatic wounds, and burns. Wound debridement aids in the removal of necrotic tissue and bacteria and senescent cells. Sharp surgical debridement resets the proper timing of the phases of wound reepithelialization.
The global wound debridement products market size is expected to be valued at US$ 561.31 million in 2019, and is expected to exhibit a CAGR of 9.2% over the forecast period (2019-2027).
Figure 1. Global Wound Debridement Products Market Value (US$ Mn), by Region, 2020
Increasing incidence of injuries and trauma are expected to propel the market growth during the forecast period
The rising incidence of injuries/trauma is expected to propel growth of the wound debridement products market. For instance, according to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S.
Moreover, the number road accidents are expected to drive the growth of wound debridement products market during the forecast period. According to the Annual Accident Report, 2018, from the European Road Safety Observatory, around 1.4 million people suffered from injuries due to traffic road accidents in the European Union in 2016.
Figure 2. Global Wound Debridement Products Market Share (%)in Terms of Value, by Application, 2019
Mergers, agreements and collaborations among players to develop new and advanced wound debridement products, are expected to drive the market growth during the forecast period
Market players are focused on adoption of inorganic growth strategies such as collaborations and partnerships to strengthen their position in the wound debridement products market. For instance, in February 2020, Bactiguard Holding AB entered an agreement to acquire Vigilenz, a Malaysian manufacturer and supplier of medical devices and consumables. Vigilenz is focused on developing products for wound care and management. Hence through this acquisition Bactiguard Holding AB will be strengthening its wound care and management product portfolio in the market.
Wound Debridement Products Market Restarints
There is a higher risk for bleeding and peri-procedural pain in surgical debridement and mechanical debridement which limits their adoption and is likely to hinder growth of the market. Moreover, lack of standard usage guidelines and trained manpower is also expected to limit growth of the market. Usage of devices such as hydrosurgical debridement devices, low frequency ultrasound, and surgical wound debridement lack standard guidelines and usage indications for various disorders. There is also lack of trained professionals to guide patients in the usage of these devices for different conditions in the long-term treatment plan.
Key Players
Major players operating in the global wound debridement products market include Smith & Nephew plc., Lohmann & Rauscher International GmbH & Co. KG (L&R Group), Medaxis, DeRoyal Industries, Inc., Monarch Labs, Arobella Medical, LLC, Zimmer Biomet, Misonix, Inc., Bactiguard AB, MediWound Ltd., and Söring GmbH.
| Wound Debridement Products Market Report Coverage |
| Report Coverage |
Details |
| Base Year: |
2019 |
Market Size in 2019: |
USD 561.3 Mn |
| Historical Data for: |
2016 to 2019 |
Forecast Period: |
2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: |
9.2% |
2027 Value Projection: |
USD 1,132.9 Mn |
| Geographies covered: |
- North America: U.S.,Canada.
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, UK, Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Africa: South Africa, North Africa, Central Africa
|
| Segments covered: |
- Product: Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices, Larval Therapy
- Application: Chronic Ulcers, Surgical Wounds, Traumatic Wounds, Burn Cases
- End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Nursing Facilities, Others
|
| Companies covered (11): |
Smith & Nephew plc., Lohmann & Rauscher International GmbH & Co. KG (L&R Group), Medaxis, DeRoyal Industries, Inc., Monarch Labs, Arobella Medical, LLC, Zimmer Biomet, Misonix, Inc., Bactiguard AB, MediWound Ltd., and Söring GmbH.
|
| Growth Drivers: |
- Increasing incidence of injuries/trauma
- Increasing product launches and approvals
|
| Restraints & Challenges: |
- Lack of standard usage guidelines and trained manpower
|
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
